The sudden emergence of severe respiratory disease, caused by a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health …

The present review was carried out to analyze the works developed using the adsorption
technology to remove the anti-inflammatory ketoprofen (KET). The main factors that inflated …

The high mortality observed in Covid-19 patients may be related to unrecognized pulmonary
embolism, pulmonary thrombosis, or other underlying cardiovascular diseases. Recent data …

Background Since the COVID-19 pandemic has occurred, nations showed their
unpreparedness to deal with a mass casualty incident of this proportion and severity, which …

COVID-19 pandemic is posing an unprecedented sanitary threat: antiviral and host-directed
medications to treat the disease are urgently needed. A great effort has been paid to find …

Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from
aggressive inflammation initiated by viral replication. There has been much speculation …

COVID‐19 is a complex disease, and many difficulties are faced today especially in the
proper choice of pharmacological treatments. The role of antiviral agents for COVID‐19 is …

The newly recognised coronavirus SARS‐CoV‐2, causative agent of coronavirus disease
(COVID‐19), has caused a pandemic with huge ramifications for human interactions around …

Non-steroidal anti-inflammatory drugs (NSAIDs) showed promising clinical efficacy toward
COVID-19 (Coronavirus disease 2019) patients as potent painkillers and anti-inflammatory …

The outbreak of coronavirus disease 2019 (COVID-19) underlined the urgent need for
alleviating cytokine storm. We propose here that activating the cholinergic anti-inflammatory …